Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0M3C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $163,202
Award facts
- Contract value 100% obligated
- $163,202.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $163,202.33 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for Menveo vaccine (1 vial, 0.5 mL) with an ultimate completion date of April 20, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside and carries a ceiling value matching the obligated amount.
Quick answers
Who was awarded contract SPE2DR26F0M3C?
SPE2DR26F0M3C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 17, 2026.
How much is contract SPE2DR26F0M3C worth?
The government has obligated $163,202 on SPE2DR26F0M3C.
Is contract SPE2DR26F0M3C an order under another contract?
Yes. SPE2DR26F0M3C is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0M3C competed?
The extent of competition for SPE2DR26F0M3C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award